United States· US:42571-275_3afc3c42-1157-b612-e063-6294a90ac179
DALFAMPRIDINE
A medicinal product containing dalfampridine, registered in United States by Micro Labs Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DALFAMPRIDINE
- Manufacturer
- Micro Labs Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1142571-275-10
- ndc1142571-275-60
- ndc114257127505500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-05)
- ndc1142571275101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-10)
- ndc11425712756060 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-60)
- ndc1142571-275-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dalfampridine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFAMPRIDIN SANDOZSandoz s.r.o., Praha
- NetherlandsFampridine Abdi 10 mg tabletten met verlengde afgifteAbdi Farma GmbH
- FinlandFampridin ZentivaZentiva, k.s.
- SpainFAMPRIDINA ACCORD 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- FranceFAMPRIDINE ACCORD 10 mg, comprimé à libération prolongéeACCORD HEALTHCARE (ESPAGNE)
- SwedenFampridin Medical Valley 10 mg DepottablettMedical Valley Invest AB
- IcelandFampridin Medical ValleyMedical Valley Invest AB
- PolandFampridine AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Fampridin Neuraxpharm, Fampridin Ratiopharm
- Cyprus · Fampridine Sandoz, Fampridine Viatris
- Czechia · Fampridin Sandoz, Fampridine Abdi
- Germany · Fampridin Abdi, Fampridin Abz
- Denmark · Fampridin "neuraxpharm", Fampridin Medical Valley
- Spain · Fampridina Aurovitas, Fampridina Qualigen
- Finland · Fampridin Medical Valley, Fampridin Zentiva
- France · Fampridine Arrow, Fampridine Eg
- United Kingdom (Northern Ireland) · Elupria, Fampridine Abdi
- Greece · Fadisa, Fampridine Sandoz
- Croatia · Fampridin Sandoz, Fampridin Teva
- Hungary · Fampridine Rontis
- Ireland · Fampridine Rowa
- Iceland · Fampridin Medical Valley, Fampridin Neuraxpharm
- Italy · Fampridina Abdi
- Liechtenstein · Fampridine Accord, Fampyra
- Luxembourg · Fampridine Eg
- Malta · Fampridine Viatris
- Netherlands · Fampridine Abdi, Fampridine Ascend
- Norway · Fampridin Medical Valley, Fampridin Neuraxpharm
- Poland · Fampridine Sandoz, Fampridine Teva
- Portugal · Fampridina Ascend, Fampridina Generis
- Sweden · Fampridin Medical Valley, Fampridin Zentiva
- Slovenia · Fampridin Stada, Fampridin Teva
- Slovakia · Fampridín Teva, Fampridine Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3b82881-a23a-4e53-8965-eff16f533d44 GET /v1/drugs/c3b82881-a23a-4e53-8965-eff16f533d44?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "DALFAMPRIDINE",
"productndc": "42571-275",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA210158",
"marketing_category": "ANDA"
}See everything about dalfampridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.